| Controversy over combination chemotherapy in advanced ovarian cancer: what we learn from reports of matured data |
| AJ Dembo |
|
JCO Nov 1 1986: 1573–1576.
[PDF]
|
 |
| New frontiers in cancer chemotherapy? |
| JO Armitage |
|
JCO Nov 1 1986: 1577–1578.
[PDF]
|
 |
|
Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma |
| |
KG Louie, RF Ozols, CE Myers, Y Ostchega, J Jenkins, D Howser, and RC Young |
| |
JCO Nov 1 1986: 1579–1585.
[Abstract]
[PDF]
|
 |
|
Phase II trial of high-dose melphalan and autologous bone marrow transplantation for metastatic colon carcinoma |
| |
RS Leff, JM Thompson, DB Johnson, KR Mosley, MB Daly, WA Knight, 3d, RL Ruxer, Jr, and GL Messerschmidt |
| |
JCO Nov 1 1986: 1586–1591.
[Abstract]
[PDF]
|
 |
|
High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer |
| |
JP Eder, K Antman, W Peters, WD Henner, A Elias, T Shea, S Schryber, J Andersen, S Come, and L Schnipper |
| |
JCO Nov 1 1986: 1592–1597.
[Abstract]
[PDF]
|
 |
|
Factors affecting survival in superior sulcus tumors |
| |
TM Anderson, PM Moy, and EC Holmes |
| |
JCO Nov 1 1986: 1598–1603.
[Abstract]
[PDF]
|
 |
|
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy |
| |
JP O'Connell, MG Kris, RJ Gralla, S Groshen, A Trust, JJ Fiore, DP Kelsen, RT Heelan, and RB Golbey |
| |
JCO Nov 1 1986: 1604–1614.
[Abstract]
[PDF]
|
 |
|
Effects of brain irradiation and chemotherapy on myelosuppression in small-cell lung cancer |
| |
JS Lee, T Umsawasdi, HM Dhingra, HT Barkley, Jr, and WK Murphy |
| |
JCO Nov 1 1986: 1615–1619.
[Abstract]
[PDF]
|
 |
|
Cerebrospinal fluid bombesin and calcitonin in patients with central nervous system metastases from small-cell lung cancer |
| |
AG Pedersen, KL Becker, F Bach, RH Snider, AF Gazdar, PS Sorensen, PA Bunn, and HH Hansen |
| |
JCO Nov 1 1986: 1620–1627.
[Abstract]
[PDF]
|
 |
|
Treatment of lymphoblastic lymphoma in adults |
| |
CN Coleman, VJ Picozzi, Jr, RS Cox, K McWhirter, LM Weiss, JR Cohen, KP Yu, and SA Rosenberg |
| |
JCO Nov 1 1986: 1628–1637.
[Abstract]
[PDF]
|
 |
|
Mycosis fungoides involving the central nervous system |
| |
D Hallahan, M Griem, S Griem, E Duda, and J Baron |
| |
JCO Nov 1 1986: 1638–1644.
[Abstract]
[PDF]
|
 |
|
Immunochemotherapy in human hepatocellular carcinoma using the streptococcal agent OK-432 |
| |
S Imaoka, Y Sasaki, O Ishikawa, H Ouhigashi, H Koyama, T Iwanaga, and S Ishiguro |
| |
JCO Nov 1 1986: 1645–1651.
[Abstract]
[PDF]
|
 |
|
Prognostic factors in metastatic carcinoma of unknown primary |
| |
R Pasterz, N Savaraj, and M Burgess |
| |
JCO Nov 1 1986: 1652–1657.
[Abstract]
[PDF]
|
 |
|
Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience |
| |
CA Presant, WO Russell, RW Alexander, and YS Fu |
| |
JCO Nov 1 1986: 1658–1661.
[Abstract]
[PDF]
|
 |
|
Cardiac metastases from soft-tissue sarcomas |
| |
DE Hallahan, NJ Vogelzang, KM Borow, DG Bostwick, and MA Simon |
| |
JCO Nov 1 1986: 1662–1669.
[Abstract]
[PDF]
|
 |
|
Sequential methotrexate, 5-fluorouracil, and cisplatin in the treatment of recurrent squamous-cell carcinoma of the head and neck: failure of hypertonic saline to reduce the nephrotoxicity of cisplatin |
| |
IW Dimery and SS Legha |
| |
JCO Nov 1 1986: 1670–1676.
[Abstract]
[PDF]
|
 |
|
Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients |
| |
R Kurzrock, MG Rosenblum, JR Quesada, SA Sherwin, LM Itri, and JU Gutterman |
| |
JCO Nov 1 1986: 1677–1683.
[Abstract]
[PDF]
|
 |
|
Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors |
| |
GJ Bosl, SP Leitner, SA Atlas, JE Sealey, JJ Preibisz, and E Scheiner |
| |
JCO Nov 1 1986: 1684–1689.
[Abstract]
[PDF]
|
 |
|
Etoposide pharmacokinetics in patients with normal and abnormal organ function |
| |
SG Arbuck, HO Douglass, WR Crom, P Goodwin, Y Silk, C Cooper, and WE Evans |
| |
JCO Nov 1 1986: 1690–1695.
[Abstract]
[PDF]
|
 |
|
The concept of an overview of cancer clinical trials with special emphasis on early breast cancer |
| |
RD Gelber and A Goldhirsch |
| |
JCO Nov 1 1986: 1696–1703.
[Abstract]
[PDF]
|
 |
|
Treatment of non-small-cell lung cancer |
| |
JL Mulshine, E Glatstein, and JC Ruckdeschel |
| |
JCO Nov 1 1986: 1704–1715.
[Abstract]
[PDF]
|
 |
| Low-grade lymphomas in young homosexual men without LAV/HTLV III infection |
| JM Andrieu, M Toledano, P Colonna, JM Tourani, and C Audroin |
|
JCO Nov 1 1986: 1716a.
[PDF]
|
 |
| Debulking surgery in ovarian cancer |
|
|
JCO Nov 1 1986: 1716b–1717.
[PDF]
|
 |
| Ten-year analysis of the NSABP B-50 study |
| PJ Goodwin, NF Boyd, and RS Bush |
|
JCO Nov 1 1986: 1718–1721.
[PDF]
|
 |